Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion type Assertion NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_head.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion description "[The survival calculated for the two groups of AML cases subdivided according to ADA levels was significantly longer (p less than 0.025) for the patients with low levels of ADA (less than 250 U/10(8) cells).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_provenance.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion evidence source_evidence_literature NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_provenance.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion SIO_000772 7049266 NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_provenance.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion wasDerivedFrom befree-20140225 NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_provenance.
- NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_assertion wasGeneratedBy ECO_0000203 NP584211.RAwFeYKG3PGivJdONEexH9HBnu74-GuW68GOeTW0tzPnQ130_provenance.